Sponsor study identifier
interventional
40
1 country
1
Study Start
August 30, 2023
Actual (reported)Primary Completion
January 1, 2025
Actual (reported)Study Completion
July 30, 2025
Actual (reported)Acne is very common, especially among young adults. After acne heals, some people are left with persistent red or pink marks, called post-acne erythema (PAE). These marks can last for several months and, in some people, may be associated with a higher risk of developing acne scars. PAE is more common in people with lighter skin. It is thought to happen because healing after acne can cause changes in the small blood vessels in the skin, making them wider and more visible. Skin irritation from some acne treatments may also contribute to the redness. There is currently no single treatment that is considered the best treatment for post-acne redness. Several treatments have shown benefits, including different types of lasers and light treatments, as well as topical creams or serums such as vitamin C, tranexamic acid, oxymetazoline, and brimonidine. Timolol, a medication that can narrow small blood vessels, has also recently shown promising results. Fractional CO₂ laser may help improve post-acne redness by stimulating skin healing and affecting the small blood vessels responsible for the redness. Other fractional lasers have also been shown to improve PAE. Vitamin C is a powerful antioxidant that can help protect and repair the skin. When applied directly to the skin, it may reduce inflammation, support collagen production, and promote healing. Studies have shown improvement in post-acne redness with topical vitamin C. Timolol is a medication that can cause narrowing of small blood vessels and may reduce the formation of new blood vessels. Because of these effects, it has recently been studied as a treatment for post-acne redness. Because there is still no established standard treatment for PAE, this study was designed to compare three approaches: fractional CO₂ laser alone, fractional CO₂ laser combined with vitamin C, and fractional CO₂ laser combined with timolol. The goal is to determine which approach provides the best improvement in post-acne redness.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
July 30, 2025
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
August 30, 2023
Actual (reported)January 1, 2025
Actual (reported)July 30, 2025
Actual (reported)October 4, 2026
Actual (reported)October 20, 2026
Actual (reported)The percentage of improvement in post-acne erythema from baseline using erythema assessment scores.
Assessment made using erythema scores as the clinician erythema assessment scale, and dermoscopy. Also, patient satisfaction assessment, and Investigator global assessment were used.
4 months
Reaching a common consensus with post-acne erythema management in future.
12 months
40 patients enrolled in the study have a left-sided split-face application of fractional CO2 monotherapy
Twenty (20) patients have right-sided application of topical vitamin C after and between sessions of fractional CO2 laser
Group B received fractional CO₂ laser plus topical Timolol(after and between laser sessions) on the right side of the face
Group A received fractional CO₂ laser plus topical Vitamin C (after and between laser sessions) on the right side of the face
Kasr Alainy, Cairo University
Cairo, Cairo Governorate, 11562, Egypt
Amiri R, Khalili M, Mohammadi S, Iranmanesh B, Aflatoonian M. Treatment protocols and efficacy of light and laser treatments in post-acne erythema. J Cosmet Dermatol. 2022 Feb;21(2):648-656. doi: 10.1111/jocd.14729. Epub 2022 Jan 5.
Alzaid M, Al-Naseem A, Al-Niaimi F, Ali FR. Topical timolol in dermatology: infantile haemangiomas and beyond. Clin Exp Dermatol. 2022 May;47(5):819-832. doi: 10.1111/ced.15021. Epub 2022 Jan 13.
Rehab Sobhi, PhD
Kasr El Aini Hospital
40 participants (actual enrollment reported by the registry).
Twenty (20) patients have right-sided application of topical timolol after and between sessions of fractional CO2 laser
Group C received left-sided application of fractional CO2 laser alone
Contact the study team to confirm eligibility.
Afra TP, Razmi T M, De D. Topical timolol for postacne erythema. J Am Acad Dermatol. 2021 Jun;84(6):e255-e256. doi: 10.1016/j.jaad.2020.04.144. Epub 2020 May 4. No abstract available.
First Submitted
October 4, 2026
First Posted
October 20, 2026
Study Start
August 30, 2023
Actual (reported)Primary Completion
January 1, 2025
Actual (reported)Study Completion
July 30, 2025
Actual (reported)Last Updated
October 20, 2026
Record last verified: 2026-10
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: